Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2 -terminal 20 peptide (PAMP)-Reference-Cited by-同舟云学术

Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2 -terminal 20 peptide (PAMP)

Published:2001-08 Issue:2 Volume:52 Page:159-164
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Wilkinson Ian B.,McEniery Carmel M.,Bongaerts Katherine H.,MacCallum Helen,Webb David J.,Cockcroft John R.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.0306-5251.2001.1420.x/fullpdf

Reference40 articles.

1. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma;Kitamura;Biochem Biophys Res Commun,1993

2. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP);Kitamura;FEBS Lett,1994

3. Adrenomedullin;Richards;Clin Sci,1996

4. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders;Cheung;Clin Sci,1997

5. Elevation of circulating proadrenomedullin N, terminal 20-peptide in thyrotoxicosis;Taniyama;Clin Endocrinol,1997

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin Receptor-Neprilysin Inhibitor Suppresses Renin-Angiotensin-Aldosterone System Activation After Cardiac Surgery Using Cardiopulmonary Bypass;Circulation Journal;2024-08-23

2. Efficacy and Safety of Sacubitril/Valsartan in Adverse Cardiovascular Event Reduction and Hypertension Control Among Asians: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Philippine Journal of Cardiology;2024-06-15

3. Impact of Sacubitril/ Valsartan on Quality Of Life and Ejection fraction of Heart Failure patients with and without Chronic Kidney Disease;Pakistan Journal of Medical Sciences;2024-05-20

4. Incidence of hyperkalemia in anuric hemodialysis patients treated with sacubitril/valsartan;Hemodialysis International;2024-04

5. The Efficacy and Safety of Sacubitril/Valsartan Compared to Valsartan in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fractions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Clinical Medicine;2024-03-09